[go: up one dir, main page]

DE602004009917D1 - Zwischenprodukt für die herstellung von pioglitazon - Google Patents

Zwischenprodukt für die herstellung von pioglitazon

Info

Publication number
DE602004009917D1
DE602004009917D1 DE602004009917T DE602004009917T DE602004009917D1 DE 602004009917 D1 DE602004009917 D1 DE 602004009917D1 DE 602004009917 T DE602004009917 T DE 602004009917T DE 602004009917 T DE602004009917 T DE 602004009917T DE 602004009917 D1 DE602004009917 D1 DE 602004009917D1
Authority
DE
Germany
Prior art keywords
pioglitazone
manufacture
intermediate product
product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE602004009917T
Other languages
English (en)
Other versions
DE602004009917T2 (de
Inventor
Lopez Ernesto Duran
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medichem SA
Original Assignee
Medichem SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medichem SA filed Critical Medichem SA
Publication of DE602004009917D1 publication Critical patent/DE602004009917D1/de
Application granted granted Critical
Publication of DE602004009917T2 publication Critical patent/DE602004009917T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55Acids; Esters

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
DE602004009917T 2003-05-09 2004-05-04 Zwischenprodukt für die herstellung von pioglitazon Expired - Fee Related DE602004009917T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ES200301075A ES2219180B1 (es) 2003-05-09 2003-05-09 Compuesto intermedio util para la preparacion de pioglitazona.
ES200301075 2003-05-09
PCT/ES2004/070031 WO2004099147A1 (es) 2003-05-09 2004-05-04 Compuesto intermedio útil para la preparación de pioglitazona

Publications (2)

Publication Number Publication Date
DE602004009917D1 true DE602004009917D1 (de) 2007-12-20
DE602004009917T2 DE602004009917T2 (de) 2008-08-21

Family

ID=33427384

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004009917T Expired - Fee Related DE602004009917T2 (de) 2003-05-09 2004-05-04 Zwischenprodukt für die herstellung von pioglitazon

Country Status (10)

Country Link
US (1) US7375231B2 (de)
EP (1) EP1623977B1 (de)
AR (1) AR044267A1 (de)
AT (1) ATE377588T1 (de)
CA (1) CA2525190A1 (de)
DE (1) DE602004009917T2 (de)
ES (2) ES2219180B1 (de)
PL (1) PL1623977T3 (de)
PT (1) PT1623977E (de)
WO (1) WO2004099147A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1957476A1 (de) * 2005-11-23 2008-08-20 AstraZeneca AB L-alaninderivate
US20090062267A1 (en) * 2007-01-29 2009-03-05 Astrazeneca Ab L-ALANINE DERIVATIVES AS a5beta1 ANTAGONISTS
WO2008125811A1 (en) * 2007-04-11 2008-10-23 Astrazeneca Ab N-[HETEROARYLCARBONYL]-S-THIENYL-L-ALANINE DERIVATIVES AS α5β1 ANTAGONISTS
WO2012177956A1 (en) * 2011-06-23 2012-12-27 Metabolic Solutions Development Comapny, Llc Ppar-sparing compounds for use in the treatment of diabetes and other metabolic diseases

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR240698A1 (es) * 1985-01-19 1990-09-28 Takeda Chemical Industries Ltd Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales
JPH08325263A (ja) * 1995-05-31 1996-12-10 Sumitomo Metal Ind Ltd 新規2−アミノ−3−フェニルプロピオン酸誘導体
JP2000344748A (ja) * 1999-03-29 2000-12-12 Welfide Corp 3−芳香族置換プロピオン酸またはアクリル酸化合物
AU2002311057A1 (en) * 2001-04-26 2002-11-11 Leciva, A.S. Method for obtaining pioglitazone as an antidiabetic agent

Also Published As

Publication number Publication date
ES2219180B1 (es) 2006-03-01
US7375231B2 (en) 2008-05-20
ES2297415T3 (es) 2008-05-01
PT1623977E (pt) 2008-01-22
AR044267A1 (es) 2005-09-07
US20070083050A1 (en) 2007-04-12
ATE377588T1 (de) 2007-11-15
ES2219180A1 (es) 2004-11-16
EP1623977B1 (de) 2007-11-07
CA2525190A1 (en) 2004-11-18
WO2004099147A1 (es) 2004-11-18
PL1623977T3 (pl) 2008-04-30
DE602004009917T2 (de) 2008-08-21
EP1623977A1 (de) 2006-02-08

Similar Documents

Publication Publication Date Title
ATE434598T1 (de) Zwischenprodukte für die herstellung von dioxan-2-alkylcarbamaten
ATE447564T1 (de) Zwischenprodukte für die herstellung von trans-5- chlor-2-methyl-2,3,3a,12b-tetrahydro-1h-dibenzä , 3:6,7üoxepinoä4,5-cüpyrrol
DE602004000740D1 (de) Herstellung von Nuten
ATE348100T1 (de) Zwischenprodukten für die herstellung von pyridazinon aldose reductase inhibitoren.
NO20053796D0 (no) Process for the production of particles
SE0301552L (sv) New product
ATE343605T1 (de) Zusammensetzungen zur herstellung von aminoplasterzeugnissen
DE60323456D1 (de) Herstellung von Nanopartikeln
IS2674B (is) Aðferð við framleiðslu á handhverfulega hreinu mírtasapíni
ITBO20030349A1 (it) Procedimento e macchina per la produzione di scatole di
DE602004004777D1 (de) Kontinuierliches verfahren für die herstellung von polyamiden
DE60238030D1 (de) Katalysatorzusammensetzung für die Herstellung von Polyolefinen
DE602004009917D1 (de) Zwischenprodukt für die herstellung von pioglitazon
ATE474824T1 (de) Herstellung von olefinen
DE602005017357D1 (de) Überwachungseinrichtung für die herstellung von zusammensetzungen
ITMI20030346A1 (it) Procedimento per la produzione di mesitilene.
ATE401299T1 (de) Verfahren für die herstellung von hydroxyethylaminen
DE602004008092D1 (de) Pressblasmaschine für die herstellung von hohlen glaswaren
DE60224968D1 (de) Prozess für die Herstellung von 5-Arylpentanolen
ATE534624T1 (de) Verfahren und zwischenprodukte für die herstellung von n-(1-benzhydryl-azetidin-3-yl)-n- phenyl-methylsulphonamid-derivaten
AT501391A5 (de) Formwerkzeug zur herstellung von formsteinen
DE10391072D2 (de) Presswerkzeug für die Herstellung von Formteilen
DE602004013311D1 (de) Neue zwischenprodukte für die herstellung therapeutisch wirksamer imidazopyridine
FI20031249A0 (fi) Menetelmä valssimaisten tuotteiden valmistukseen
DE60319439D1 (de) Verfahren zur herstellung von langkettigen alkoholen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee